NEW YORK, September 24, 2015 /PRNewswire/ --

Equity Research Institute has initiated coverage on the following equities: Great Basin Scientific Inc. (NASDAQ: GBSN), Agilent Technologies Inc. (NYSE: A), Thermo Fisher Scientific Inc. (NYSE: TMO), Exact Sciences Corporation (NASDAQ: EXAS), and DexCom Inc. (NASDAQ: DXCM). Free research report on Great Basin Scientific can be accessed at https://www.erionline.net/GBSN.pdf On Wednesday, September 23, 2015, the NASDAQ Composite ended at 4,752.74, down 0.08%, the Dow Jones Industrial Average edged 0.31% lower, to finish the day at 16,279.89, and the S&P 500 closed at 1,938.76, down 0.20%. The losses were broad based as all the sectors ended the session in negative. Register for your complimentary reports at the links given below.  

Great Basin Scientific Inc.'s stock advanced 4.40%, to close the day at $0.09. The stock recorded a trading volume of 44.64 million shares, much above its three months average volume of 9.54 million shares. Over the last one month and over the past three months, Great Basin Scientific Inc.'s shares have declined 90.95% and 97.04%, respectively. Furthermore, the stock has plummeted 96.14% since the start of this year. The company's shares are trading 93.96% below their 50-day moving average. Additionally, Great Basin Scientific Inc. has a Relative Strength Index (RSI) of 14.38. Sign up and read the free notes on GBSN at:

https://www.erionline.net/GBSN.pdf

On Wednesday, shares in Agilent Technologies Inc. recorded a trading volume of 1.96 million shares, lower than their three months average volume of 2.59 million shares. The stock ended the day 0.29% lower at $34.95. Shares of the company traded at a PE ratio of 36.79. Although, Agilent Technologies Inc.'s stock has advanced 0.78% in the last one month, it has lost 12.82% in the previous three months and 14.00% on YTD basis. The company is trading below its 50-day and 200-day moving averages by 8.08% and 12.73%, respectively. Furthermore, shares of Agilent Technologies Inc. have an RSI of 38.98. The complimentary notes on A can be downloaded in PDF format at:

https://www.erionline.net/A.pdf

Thermo Fisher Scientific Inc.'s stock edged 0.50% lower, to close Wednesday's session at $124.62. The stock recorded a trading volume of 1.33 million shares, below its three months average volume of 1.79 million shares. Over the previous three months and since the start of this year, Thermo Fisher Scientific Inc.'s shares have fallen by 4.22% and 0.18%, respectively. However, the stock has gained 2.55% in the last one month. The company is trading 4.95% and 3.78% below its 50-day and 200-day moving averages, respectively. Furthermore, Thermo Fisher Scientific Inc.'s stock traded at a PE ratio of 25.48 and has an RSI of 45.32. Register for free on Equity Research Institute and access the latest research on TMO at:

https://www.erionline.net/TMO.pdf

Exact Sciences Corp.'s stock finished Wednesday's session 1.00% higher at $19.19. A total of 0.91 million shares were traded, which was below its three months average volume of 1.43 million shares. Over the last one month and the previous three months, Exact Sciences Corp.'s shares have declined 1.82% and 38.41%, respectively. Additionally, the stock has lost 30.07% since the beginning of 2015. The company's shares are trading below their 50-day and 200-day moving averages by 15.55% and 23.05%, respectively. Exact Sciences Corp.'s stock has an RSI of 36.18. The complete research on EXAS is available for free at:

https://www.erionline.net/EXAS.pdf

On Wednesday, shares in DexCom Inc. ended the session 3.18% higher at $100.55. The stock reported a trading volume of 0.89 million shares, below its three months average volume of 1.09 million shares. DexCom Inc.'s shares have surged 17.62% in the last one month, 30.42% in the previous three months and 82.65% on YTD basis. The company is trading 11.10% above its 50-day moving average and 40.87% above its 200-day moving average. Moreover, shares of DexCom Inc. have an RSI of 62.82. Free in-depth research on DXCM is available at:

https://www.erionline.net/DXCM.pdf

--

About Equity Research Institute: 

Equity Research Institute ("ERI") produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. ERI has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

ERI has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:  

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer"). Rohit Tuli, a CFA(R) charter holder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on sound investment judgment and publicly available information which is believed to be reliable. The Reviewer and the Sponsor have not performed any independent investigations or forensic audits to validate the information herein. Unless otherwise noted, any content outside of this document has no association with the Author, the Reviewer, or the Sponsor (collectively referred to as the "Production Team") in any way. The Production Team is compensated on a fixed monthly basis and do not hold any positions of interest in any of the securities mentioned herein.

NO WARRANTY 

ERI, the Author, the Reviewer and the Sponsor (collectively referred to as the "Publishers") are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by the Publishers whatsoever for any direct, indirect or consequential loss arising from the use of this document. The Publishers expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, the Publishers do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING 

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither ERI nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.erionline.net.

RESTRICTIONS 

ERI is not available to residents of Belarus, Cuba, Canada, Iran, North Korea, Sudan, Syria or Somalia.

CFA(R) and Chartered Financial Analyst(R) are registered trademarks owned by CFA Institute.

SOURCE www.erionline.net